Cargando…

Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma In Vivo and In Vitro

Naturally-occurring mixtures of phytochemicals present in plant foods are proposed to possess tumor-suppressive activities. In this work, we aimed to evaluate the antitumor effects of Thymus vulgaris L. in in vivo and in vitro mammary carcinoma models. Dried T. vulgaris (as haulm) was continuously a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubatka, Peter, Uramova, Sona, Kello, Martin, Kajo, Karol, Samec, Marek, Jasek, Karin, Vybohova, Desanka, Liskova, Alena, Mojzis, Jan, Adamkov, Marian, Zubor, Pavol, Smejkal, Karel, Svajdlenka, Emil, Solar, Peter, Samuel, Samson Mathews, Zulli, Anthony, Kassayova, Monika, Lasabova, Zora, Kwon, Taeg Kyu, Pec, Martin, Danko, Jan, Büsselberg, Dietrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479806/
https://www.ncbi.nlm.nih.gov/pubmed/30970626
http://dx.doi.org/10.3390/ijms20071749
_version_ 1783413430178283520
author Kubatka, Peter
Uramova, Sona
Kello, Martin
Kajo, Karol
Samec, Marek
Jasek, Karin
Vybohova, Desanka
Liskova, Alena
Mojzis, Jan
Adamkov, Marian
Zubor, Pavol
Smejkal, Karel
Svajdlenka, Emil
Solar, Peter
Samuel, Samson Mathews
Zulli, Anthony
Kassayova, Monika
Lasabova, Zora
Kwon, Taeg Kyu
Pec, Martin
Danko, Jan
Büsselberg, Dietrich
author_facet Kubatka, Peter
Uramova, Sona
Kello, Martin
Kajo, Karol
Samec, Marek
Jasek, Karin
Vybohova, Desanka
Liskova, Alena
Mojzis, Jan
Adamkov, Marian
Zubor, Pavol
Smejkal, Karel
Svajdlenka, Emil
Solar, Peter
Samuel, Samson Mathews
Zulli, Anthony
Kassayova, Monika
Lasabova, Zora
Kwon, Taeg Kyu
Pec, Martin
Danko, Jan
Büsselberg, Dietrich
author_sort Kubatka, Peter
collection PubMed
description Naturally-occurring mixtures of phytochemicals present in plant foods are proposed to possess tumor-suppressive activities. In this work, we aimed to evaluate the antitumor effects of Thymus vulgaris L. in in vivo and in vitro mammary carcinoma models. Dried T. vulgaris (as haulm) was continuously administered at two concentrations of 0.1% and 1% in the diet in a chemically-induced rat mammary carcinomas model and a syngeneic 4T1 mouse model. After autopsy, histopathological and molecular analyses of rodent mammary carcinomas were performed. In addition, in vitro evaluations using MCF-7 and MDA-MB-231 cells were carried out. In mice, T. vulgaris at both doses reduced the volume of 4T1 tumors by 85% (0.1%) and 84% (1%) compared to the control, respectively. Moreover, treated tumors showed a substantial decrease in necrosis/tumor area ratio and mitotic activity index. In the rat model, T. vulgaris (1%) decreased the tumor frequency by 53% compared to the control. Analysis of the mechanisms of anticancer action included well-described and validated diagnostic and prognostic markers that are used in both clinical approach and preclinical research. In this regard, the analyses of treated rat carcinoma cells showed a CD44 and ALDH1A1 expression decrease and Bax expression increase. Malondialdehyde (MDA) levels and VEGFR-2 expression were decreased in rat carcinomas in both the T. vulgaris treated groups. Regarding the evaluations of epigenetic changes in rat tumors, we found a decrease in the lysine methylation status of H3K4me3 in both treated groups (H3K9m3, H4K20m3, and H4K16ac were not changed); up-regulations of miR22, miR34a, and miR210 expressions (only at higher doses); and significant reductions in the methylation status of four gene promoters—ATM serin/threonine kinase, also known as the NPAT gene (ATM); Ras-association domain family 1, isoform A (RASSF1); phosphatase and tensin homolog (PTEN); and tissue inhibitor of metalloproteinase-3 (TIMP3) (the paired-like homeodomain transcription factor (PITX2) promoter was not changed). In vitro study revealed the antiproliferative and proapoptotic effects of essential oils of T. vulgaris in MCF-7 and MDA-MB-231 cells (analyses of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS); 5-bromo-20-deoxyuridine (BrdU); cell cycle; annexin V/PI; caspase-3/7; Bcl-2; PARP; and mitochondrial membrane potential). T. vulgaris L. demonstrated significant chemopreventive and therapeutic activities against experimental breast carcinoma.
format Online
Article
Text
id pubmed-6479806
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64798062019-04-29 Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma In Vivo and In Vitro Kubatka, Peter Uramova, Sona Kello, Martin Kajo, Karol Samec, Marek Jasek, Karin Vybohova, Desanka Liskova, Alena Mojzis, Jan Adamkov, Marian Zubor, Pavol Smejkal, Karel Svajdlenka, Emil Solar, Peter Samuel, Samson Mathews Zulli, Anthony Kassayova, Monika Lasabova, Zora Kwon, Taeg Kyu Pec, Martin Danko, Jan Büsselberg, Dietrich Int J Mol Sci Article Naturally-occurring mixtures of phytochemicals present in plant foods are proposed to possess tumor-suppressive activities. In this work, we aimed to evaluate the antitumor effects of Thymus vulgaris L. in in vivo and in vitro mammary carcinoma models. Dried T. vulgaris (as haulm) was continuously administered at two concentrations of 0.1% and 1% in the diet in a chemically-induced rat mammary carcinomas model and a syngeneic 4T1 mouse model. After autopsy, histopathological and molecular analyses of rodent mammary carcinomas were performed. In addition, in vitro evaluations using MCF-7 and MDA-MB-231 cells were carried out. In mice, T. vulgaris at both doses reduced the volume of 4T1 tumors by 85% (0.1%) and 84% (1%) compared to the control, respectively. Moreover, treated tumors showed a substantial decrease in necrosis/tumor area ratio and mitotic activity index. In the rat model, T. vulgaris (1%) decreased the tumor frequency by 53% compared to the control. Analysis of the mechanisms of anticancer action included well-described and validated diagnostic and prognostic markers that are used in both clinical approach and preclinical research. In this regard, the analyses of treated rat carcinoma cells showed a CD44 and ALDH1A1 expression decrease and Bax expression increase. Malondialdehyde (MDA) levels and VEGFR-2 expression were decreased in rat carcinomas in both the T. vulgaris treated groups. Regarding the evaluations of epigenetic changes in rat tumors, we found a decrease in the lysine methylation status of H3K4me3 in both treated groups (H3K9m3, H4K20m3, and H4K16ac were not changed); up-regulations of miR22, miR34a, and miR210 expressions (only at higher doses); and significant reductions in the methylation status of four gene promoters—ATM serin/threonine kinase, also known as the NPAT gene (ATM); Ras-association domain family 1, isoform A (RASSF1); phosphatase and tensin homolog (PTEN); and tissue inhibitor of metalloproteinase-3 (TIMP3) (the paired-like homeodomain transcription factor (PITX2) promoter was not changed). In vitro study revealed the antiproliferative and proapoptotic effects of essential oils of T. vulgaris in MCF-7 and MDA-MB-231 cells (analyses of 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS); 5-bromo-20-deoxyuridine (BrdU); cell cycle; annexin V/PI; caspase-3/7; Bcl-2; PARP; and mitochondrial membrane potential). T. vulgaris L. demonstrated significant chemopreventive and therapeutic activities against experimental breast carcinoma. MDPI 2019-04-09 /pmc/articles/PMC6479806/ /pubmed/30970626 http://dx.doi.org/10.3390/ijms20071749 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kubatka, Peter
Uramova, Sona
Kello, Martin
Kajo, Karol
Samec, Marek
Jasek, Karin
Vybohova, Desanka
Liskova, Alena
Mojzis, Jan
Adamkov, Marian
Zubor, Pavol
Smejkal, Karel
Svajdlenka, Emil
Solar, Peter
Samuel, Samson Mathews
Zulli, Anthony
Kassayova, Monika
Lasabova, Zora
Kwon, Taeg Kyu
Pec, Martin
Danko, Jan
Büsselberg, Dietrich
Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma In Vivo and In Vitro
title Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma In Vivo and In Vitro
title_full Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma In Vivo and In Vitro
title_fullStr Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma In Vivo and In Vitro
title_full_unstemmed Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma In Vivo and In Vitro
title_short Anticancer Activities of Thymus vulgaris L. in Experimental Breast Carcinoma In Vivo and In Vitro
title_sort anticancer activities of thymus vulgaris l. in experimental breast carcinoma in vivo and in vitro
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479806/
https://www.ncbi.nlm.nih.gov/pubmed/30970626
http://dx.doi.org/10.3390/ijms20071749
work_keys_str_mv AT kubatkapeter anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT uramovasona anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT kellomartin anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT kajokarol anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT samecmarek anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT jasekkarin anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT vybohovadesanka anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT liskovaalena anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT mojzisjan anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT adamkovmarian anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT zuborpavol anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT smejkalkarel anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT svajdlenkaemil anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT solarpeter anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT samuelsamsonmathews anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT zullianthony anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT kassayovamonika anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT lasabovazora anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT kwontaegkyu anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT pecmartin anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT dankojan anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro
AT busselbergdietrich anticanceractivitiesofthymusvulgarislinexperimentalbreastcarcinomainvivoandinvitro